Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Nanolattix Biotechnology Co., Ltd., explained in plain language.
This early-stage study is testing a new radioactive tracer called RT01-89Zr that attaches to a protein found on many solid tumors. The goal is to see if it is safe and can make tumors show up more clearly on PET/CT scans. Ten adults with confirmed solid tumors will receive the tr…
Phase: EARLY_PHASE1 • Sponsor: Nanolattix Biotechnology Co., Ltd. • Aim: Diagnosis
Last updated May 17, 2026 00:28 UTC